Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$17.79
0.221.25%
At close: -
$17.91
0.120.67%
After Hours: 6:46 PM EDT
Comments
Loading...
Staar Surgical Analyst Ratings and Price Targets | NASDAQ:STAA | Benzinga
Staar Surgical Co has a consensus price target of $48.55 based on the ratings of 15 analysts. The high is $125 issued by Jefferies on August 11, 2022. The low is $16 issued by Piper Sandler on February 12, 2025. The 3 most-recent analyst ratings were released by Stephens & Co., Canaccord Genuity, and Stifel on March 18, 2025, February 13, 2025, and February 12, 2025, respectively. With an average price target of $18 between Stephens & Co., Canaccord Genuity, and Stifel, there's an implied 0.50% upside for Staar Surgical Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stephens & Co.
Canaccord Genuity
Stifel
Piper Sandler
BTIG
1calculated from analyst ratings
Analyst Ratings for Staar Surgical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | Buy Now | -5.08% | Stephens & Co. | Mason Carrico41% | $17 → $17 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 02/27/2025 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | Hold → Hold | Get Alert |
| 02/13/2025 | Buy Now | -5.08% | Canaccord Genuity | Jon Young62% | $28 → $17 | Maintains | Hold | Get Alert |
| 02/12/2025 | Buy Now | 11.67% | Stifel | Thomas Stephan41% | $38 → $20 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | 56.34% | Stephens & Co. | Mason Carrico41% | $28 → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 02/12/2025 | Buy Now | -10.66% | Piper Sandler | Matt O'Brien51% | $40 → $16 | Maintains | Neutral | Get Alert |
| 02/12/2025 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | Hold → Hold | Get Alert |
| 02/12/2025 | Buy Now | — | William Blair | Margaret Kaczor37% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/07/2025 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | Hold → Hold | Get Alert |
| 12/09/2024 | Buy Now | 56.34% | Canaccord Genuity | Jon Young62% | $31 → $28 | Maintains | Hold | Get Alert |
| 11/01/2024 | Buy Now | 73.09% | Canaccord Genuity | Jon Young62% | $41 → $31 | Maintains | Hold | Get Alert |
| 10/31/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 09/19/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 08/26/2024 | Buy Now | 145.67% | Stifel | Thomas Stephan41% | $50 → $44 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 128.92% | Canaccord Genuity | Jon Young62% | $43 → $41 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 07/15/2024 | Buy Now | 195.92% | BTIG | Ryan Zimmerman73% | $46 → $53 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 106.59% | Morgan Stanley | Patrick Wood53% | $50 → $37 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/15/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 06/11/2024 | Buy Now | 156.84% | BTIG | Ryan Zimmerman73% | → $46 | Upgrade | Neutral → Buy | Get Alert |
| 05/08/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 05/08/2024 | Buy Now | 140.09% | Canaccord Genuity | Jon Young62% | $46 → $43 | Maintains | Hold | Get Alert |
| 05/08/2024 | Buy Now | 123.34% | Piper Sandler | Matt O'Brien51% | $33 → $40 | Maintains | Neutral | Get Alert |
| 05/08/2024 | Buy Now | 207.09% | Mizuho | Anthony Petrone64% | $53 → $55 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | 195.92% | Mizuho | Anthony Petrone64% | $45 → $53 | Maintains | Buy | Get Alert |
| 04/08/2024 | Buy Now | 156.84% | Canaccord Genuity | Jon Young62% | $32 → $46 | Maintains | Hold | Get Alert |
| 04/04/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 04/01/2024 | Buy Now | 179.17% | Stifel | Thomas Stephan41% | $50 → $50 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | 179.17% | Stifel | Thomas Stephan41% | $30 → $50 | Upgrade | Hold → Buy | Get Alert |
| 02/28/2024 | Buy Now | 151.26% | Mizuho | Anthony Petrone64% | $50 → $45 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | 84.25% | Piper Sandler | Matt O'Brien51% | $40 → $33 | Maintains | Neutral | Get Alert |
| 12/05/2023 | Buy Now | — | Needham | David Saxon54% | — | Downgrade | Buy → Hold | Get Alert |
| 12/04/2023 | Buy Now | 95.42% | Morgan Stanley | Patrick Wood53% | → $35 | Initiates | → Equal-Weight | Get Alert |
| 11/02/2023 | Buy Now | 123.34% | Piper Sandler | Matt O'Brien51% | $45 → $40 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | 173.59% | Needham | David Saxon54% | $52 → $49 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | 123.34% | Stifel | Thomas Stephan41% | $45 → $40 | Maintains | Hold | Get Alert |
| 09/15/2023 | Buy Now | 151.26% | Piper Sandler | Matt O'Brien51% | $50 → $45 | Maintains | Neutral | Get Alert |
| 09/15/2023 | Buy Now | 262.93% | Mizuho | Anthony Petrone64% | → $65 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | Buy Now | — | Benchmark | Bruce Jackson41% | — | Downgrade | Buy → Hold | Get Alert |
| 09/15/2023 | Buy Now | 190.34% | Needham | David Saxon54% | $54 → $52 | Maintains | Buy | Get Alert |
| 09/13/2023 | Buy Now | 262.93% | Mizuho | Anthony Petrone64% | → $65 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2023 | Buy Now | 151.26% | Stifel | Thomas Stephan41% | → $45 | Reiterates | Hold → Hold | Get Alert |
| 08/21/2023 | Buy Now | 151.26% | Stifel | Thomas Stephan41% | $50 → $45 | Maintains | Hold | Get Alert |
| 08/14/2023 | Buy Now | 218.26% | Stephens & Co. | George Sellers38% | → $57 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | 218.26% | Stephens & Co. | George Sellers38% | $71 → $57 | Maintains | Overweight | Get Alert |
| 08/03/2023 | Buy Now | 179.17% | Piper Sandler | Matt O'Brien51% | $65 → $50 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | 223.84% | Needham | David Saxon54% | $75 → $58 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 168.01% | Canaccord Genuity | William Plovanic58% | $77 → $48 | Downgrade | Buy → Hold | Get Alert |
| 06/12/2023 | Buy Now | 207.09% | Stifel | Thomas Stephan41% | $60 → $55 | Maintains | Hold | Get Alert |
| 06/08/2023 | Buy Now | 329.93% | Canaccord Genuity | William Plovanic58% | → $77 | Reiterates | → Buy | Get Alert |
| 06/07/2023 | Buy Now | — | William Blair | Margaret Kaczor37% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/24/2023 | Buy Now | 318.76% | Needham | David Saxon54% | → $75 | Reiterates | Buy → Buy | Get Alert |
| 05/04/2023 | Buy Now | 374.6% | Stephens & Co. | George Sellers38% | → $85 | Reiterates | → Overweight | Get Alert |
| 05/04/2023 | Buy Now | 369.01% | Needham | David Saxon54% | $78 → $84 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 262.93% | Piper Sandler | Matt O'Brien51% | → $65 | Initiates | → Neutral | Get Alert |
| 02/22/2023 | Buy Now | 374.6% | Stephens & Co. | George Sellers38% | → $85 | Reiterates | → Overweight | Get Alert |
| 02/22/2023 | Buy Now | 335.51% | Needham | David Saxon54% | $83 → $78 | Maintains | Buy | Get Alert |
| 02/06/2023 | Buy Now | — | BTIG | Ryan Zimmerman73% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/01/2023 | Buy Now | 318.76% | Benchmark | Bruce Jackson41% | $78 → $75 | Maintains | Buy | Get Alert |
| 01/30/2023 | Buy Now | 346.68% | Canaccord Genuity | William Plovanic58% | $79 → $80 | Maintains | Buy | Get Alert |
| 01/20/2023 | Buy Now | 341.09% | Canaccord Genuity | William Plovanic58% | $76 → $79 | Maintains | Buy | Get Alert |
| 12/28/2022 | Buy Now | 374.6% | Stephens & Co. | George Sellers38% | $91 → $85 | Maintains | Overweight | Get Alert |
| 12/08/2022 | Buy Now | 235.01% | Stifel | Thomas Stephan41% | → $60 | Initiates | → Hold | Get Alert |
| 11/07/2022 | Buy Now | — | Sidoti & Co. | James Sidoti65% | — | Upgrade | Neutral → Buy | Get Alert |
| 11/03/2022 | Buy Now | 346.68% | BTIG | Ryan Zimmerman73% | $103 → $80 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | 363.43% | Needham | David Saxon54% | $110 → $83 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | 391.35% | Canaccord Genuity | William Plovanic58% | $97 → $88 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | 408.1% | Stephens & Co. | George Sellers38% | → $91 | Reinstates | → Overweight | Get Alert |
| 10/13/2022 | Buy Now | 374.6% | Mizuho | Anthony Petrone64% | → $85 | Initiates | → Buy | Get Alert |
| 08/11/2022 | Buy Now | 597.93% | Jefferies | Zachary Weiner2% | $165 → $125 | Maintains | Buy | Get Alert |
| 08/11/2022 | Buy Now | 553.27% | Benchmark | Bruce Jackson41% | $97 → $117 | Maintains | Buy | Get Alert |
| 08/11/2022 | Buy Now | 514.18% | Needham | David Saxon54% | $87 → $110 | Maintains | Buy | Get Alert |
| 04/26/2022 | Buy Now | 396.93% | Canaccord Genuity | Jason Mills81% | $81 → $89 | Maintains | Buy | Get Alert |
| 04/08/2022 | Buy Now | 385.76% | Needham | David Saxon54% | → $87 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Staar Surgical (STAA) stock?
The latest price target for Staar Surgical (NASDAQ:STAA) was reported by Stephens & Co. on March 18, 2025. The analyst firm set a price target for $17.00 expecting STAA to fall to within 12 months (a possible -5.08% downside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Staar Surgical (STAA)?
The latest analyst rating for Staar Surgical (NASDAQ:STAA) was provided by Stephens & Co., and Staar Surgical reiterated their equal-weight rating.
When was the last upgrade for Staar Surgical (STAA)?
The last upgrade for Staar Surgical Co happened on June 11, 2024 when BTIG raised their price target to $46. BTIG previously had a neutral for Staar Surgical Co.
When was the last downgrade for Staar Surgical (STAA)?
The last downgrade for Staar Surgical Co happened on February 12, 2025 when William Blair changed their price target from N/A to N/A for Staar Surgical Co.
When is the next analyst rating going to be posted or updated for Staar Surgical (STAA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Staar Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Staar Surgical was filed on March 18, 2025 so you should expect the next rating to be made available sometime around March 18, 2026.
Is the Analyst Rating Staar Surgical (STAA) correct?
While ratings are subjective and will change, the latest Staar Surgical (STAA) rating was a reiterated with a price target of $17.00 to $17.00. The current price Staar Surgical (STAA) is trading at is $17.91, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.